10-Nov-2025
Benzinga (Mon, 10-Nov 12:58 PM ET)
TipRanks (Fri, 7-Nov 7:10 AM ET)
Business Wire (Wed, 5-Nov 8:30 AM ET)
HCA Healthcare, Inc. to Present at November Healthcare Conferences
Business Wire (Fri, 31-Oct 4:00 PM ET)
HCA Announces Proposed Public Offering of Senior Notes
Business Wire (Mon, 27-Oct 8:07 AM ET)
Market Chameleon (Fri, 24-Oct 7:47 AM ET)
HCA Healthcare Lifts 2025 Outlook Amid Double-Digit EPS Growth and Robust Patient Volumes
Market Chameleon (Fri, 24-Oct 3:33 AM ET)
HCA Healthcare Reports Third Quarter 2025 Results
Business Wire (Fri, 24-Oct 7:00 AM ET)
HCA Healthcare to Host Seventh Annual "Crush the Crisis" National Prescription Drug Take Back Day
Business Wire (Tue, 21-Oct 8:30 AM ET)
HCA Healthcare Presents 2025 Awards of Distinction
Business Wire (Tue, 30-Sep 4:30 PM ET)
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2024, the firm owned and operated 190 hospitals, 124 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.
Hca Healthcare trades on the NYSE stock market under the symbol HCA.
As of November 10, 2025, HCA stock price declined to $459.30 with 1,605,785 million shares trading.
HCA has a beta of 0.24, meaning it tends to be less sensitive to market movements. HCA has a correlation of 0.03 to the broad based SPY ETF.
HCA has a market cap of $104.81 billion. This is considered a Large Cap stock.
Last quarter Hca Healthcare reported $19 billion in Revenue and $6.96 earnings per share. This beat revenue expectation by $625 million and exceeded earnings estimates by $1.26.
In the last 3 years, HCA traded as high as $478.88 and as low as $215.96.
The top ETF exchange traded funds that HCA belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
HCA has outperformed the market in the last year with a return of +30.5%, while the SPY ETF gained +15.1%. In the last 3 month period, HCA beat the market returning +20.5%, while SPY returned +7.2%. However, in the most recent 2 weeks HCA has underperformed the stock market by returning -1.8%, while SPY returned -0.6%.
HCA support price is $468.05 and resistance is $485.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HCA shares will trade within this expected range on the day.